ID   SLK_HUMAN               Reviewed;        1235 AA.
AC   Q9H2G2; D3DRA0; D3DRA1; O00211; Q6P1Z4; Q86WU7; Q86WW1; Q92603;
AC   Q9NQL0; Q9NQL1;
DT   02-MAY-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   15-MAR-2017, entry version 154.
DE   RecName: Full=STE20-like serine/threonine-protein kinase;
DE            Short=STE20-like kinase;
DE            Short=hSLK;
DE            EC=2.7.11.1;
DE   AltName: Full=CTCL tumor antigen se20-9;
DE   AltName: Full=STE20-related serine/threonine-protein kinase;
DE            Short=STE20-related kinase;
DE   AltName: Full=Serine/threonine-protein kinase 2;
GN   Name=SLK; Synonyms=KIAA0204, STK2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), TISSUE SPECIFICITY,
RP   PHOSPHORYLATION, AND MUTAGENESIS OF LYS-63.
RC   TISSUE=Lung carcinoma;
RX   PubMed=10699464; DOI=10.1016/S0167-4889(99)00164-0;
RA   Yamada E., Tsujikawa K., Itoh S., Kameda Y., Kohama Y., Yamamoto H.;
RT   "Molecular cloning and characterization of a novel human STE20-like
RT   kinase, hSLK.";
RL   Biochim. Biophys. Acta 1495:250-262(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Testis;
RX   PubMed=11149944; DOI=10.1073/pnas.98.2.629;
RA   Eichmueller S., Usener D., Dummer R., Stein A., Thiel D.,
RA   Schadendorf D.;
RT   "Serological detection of cutaneous T-cell lymphoma-associated
RT   antigens.";
RL   Proc. Natl. Acad. Sci. U.S.A. 98:629-634(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Bone marrow;
RX   PubMed=9039502; DOI=10.1093/dnares/3.5.321;
RA   Nagase T., Seki N., Ishikawa K., Ohira M., Kawarabayasi Y., Ohara O.,
RA   Tanaka A., Kotani H., Miyajima N., Nomura N.;
RT   "Prediction of the coding sequences of unidentified human genes. VI.
RT   The coding sequences of 80 new genes (KIAA0201-KIAA0280) deduced by
RT   analysis of cDNA clones from cell line KG-1 and brain.";
RL   DNA Res. 3:321-329(1996).
RN   [4]
RP   SEQUENCE REVISION.
RA   Ohara O., Nagase T., Kikuno R., Nomura N.;
RL   Submitted (AUG-1996) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Cahill P., Camire D.,
RA   Carter N.P., Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Corby N., Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L.,
RA   Frankish A., Frankland J.A., Garner P., Garnett J., Gribble S.,
RA   Griffiths C., Grocock R., Gustafson E., Hammond S., Harley J.L.,
RA   Hart E., Heath P.D., Ho T.P., Hopkins B., Horne J., Howden P.J.,
RA   Huckle E., Hynds C., Johnson C., Johnson D., Kana A., Kay M.,
RA   Kimberley A.M., Kershaw J.K., Kokkinaki M., Laird G.K., Lawlor S.,
RA   Lee H.M., Leongamornlert D.A., Laird G., Lloyd C., Lloyd D.M.,
RA   Loveland J., Lovell J., McLaren S., McLay K.E., McMurray A.,
RA   Mashreghi-Mohammadi M., Matthews L., Milne S., Nickerson T.,
RA   Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., Ross M.T.,
RA   Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W.,
RA   Tracey A., Tromans A., Tsolas J., Wall M., Walsh J., Wang H.,
RA   Weinstock K., West A.P., Willey D.L., Whitehead S.L., Wilming L.,
RA   Wray P.W., Young L., Chen Y., Lovering R.C., Moschonas N.K.,
RA   Siebert R., Fechtel K., Bentley D., Durbin R.M., Hubbard T.,
RA   Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Testis, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-189; SER-330; SER-565
RP   AND SER-655, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-189; SER-347; SER-348;
RP   SER-571; SER-777; SER-779 AND SER-818, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-189; SER-344 AND
RP   SER-565, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-779, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-189; SER-571; SER-779
RP   AND THR-1097, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-14; SER-347; SER-348;
RP   SER-565 AND SER-571, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-14; SER-189; SER-341;
RP   SER-518; SER-565; SER-571; SER-779; THR-814 AND SER-818, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-372; SER-518; SER-565;
RP   THR-569 AND SER-571, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [17]
RP   VARIANTS [LARGE SCALE ANALYSIS] LYS-405; TYR-552; GLN-604; GLY-658;
RP   THR-679; ASN-683 AND ILE-697.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Mediates apoptosis and actin stress fiber dissolution.
CC       {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- INTERACTION:
CC       Self; NbExp=3; IntAct=EBI-1022272, EBI-1022272;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9H2G2-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9H2G2-2; Sequence=VSP_018100;
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed. Highest expression is
CC       found in heart and in skeletal muscle.
CC       {ECO:0000269|PubMed:10699464}.
CC   -!- PTM: Proteolytically cleaved by caspase-3.
CC   -!- PTM: Autophosphorylated. {ECO:0000269|PubMed:10699464}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. STE Ser/Thr
CC       protein kinase family. STE20 subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH47762.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence starting in position 611.; Evidence={ECO:0000305};
CC       Sequence=AAH47885.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence starting in position 422.; Evidence={ECO:0000305};
CC       Sequence=AAH64804.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence starting in position 614.; Evidence={ECO:0000305};
CC       Sequence=BAA13195.2; Type=Frameshift; Positions=1172; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB002804; BAA19655.1; -; mRNA.
DR   EMBL; AF273048; AAG34908.1; -; mRNA.
DR   EMBL; D86959; BAA13195.2; ALT_SEQ; mRNA.
DR   EMBL; AL360170; CAH70403.1; -; Genomic_DNA.
DR   EMBL; AL138761; CAH70403.1; JOINED; Genomic_DNA.
DR   EMBL; AL360170; CAH70404.1; -; Genomic_DNA.
DR   EMBL; AL138761; CAH70404.1; JOINED; Genomic_DNA.
DR   EMBL; AL138761; CAI12395.1; -; Genomic_DNA.
DR   EMBL; AL360170; CAI12395.1; JOINED; Genomic_DNA.
DR   EMBL; AL138761; CAI12396.1; -; Genomic_DNA.
DR   EMBL; AL360170; CAI12396.1; JOINED; Genomic_DNA.
DR   EMBL; CH471066; EAW49615.1; -; Genomic_DNA.
DR   EMBL; CH471066; EAW49616.1; -; Genomic_DNA.
DR   EMBL; CH471066; EAW49617.1; -; Genomic_DNA.
DR   EMBL; CH471066; EAW49618.1; -; Genomic_DNA.
DR   EMBL; BC047762; AAH47762.1; ALT_SEQ; mRNA.
DR   EMBL; BC047885; AAH47885.1; ALT_SEQ; mRNA.
DR   EMBL; BC064804; AAH64804.1; ALT_SEQ; mRNA.
DR   EMBL; BC111565; AAI11566.1; -; mRNA.
DR   CCDS; CCDS7553.1; -. [Q9H2G2-1]
DR   CCDS; CCDS76334.1; -. [Q9H2G2-2]
DR   RefSeq; NP_001291672.1; NM_001304743.1. [Q9H2G2-2]
DR   RefSeq; NP_055535.2; NM_014720.3. [Q9H2G2-1]
DR   UniGene; Hs.591922; -.
DR   PDB; 2J51; X-ray; 2.10 A; A=19-320.
DR   PDB; 2JFL; X-ray; 2.20 A; A=19-320.
DR   PDB; 2JFM; X-ray; 2.85 A; A=19-320.
DR   PDB; 2UV2; X-ray; 2.30 A; A=19-320.
DR   PDB; 4USF; X-ray; 1.75 A; A/B=19-320.
DR   PDBsum; 2J51; -.
DR   PDBsum; 2JFL; -.
DR   PDBsum; 2JFM; -.
DR   PDBsum; 2UV2; -.
DR   PDBsum; 4USF; -.
DR   ProteinModelPortal; Q9H2G2; -.
DR   SMR; Q9H2G2; -.
DR   BioGrid; 115096; 23.
DR   IntAct; Q9H2G2; 5.
DR   MINT; MINT-4539212; -.
DR   STRING; 9606.ENSP00000358770; -.
DR   BindingDB; Q9H2G2; -.
DR   ChEMBL; CHEMBL4202; -.
DR   GuidetoPHARMACOLOGY; 2200; -.
DR   iPTMnet; Q9H2G2; -.
DR   PhosphoSitePlus; Q9H2G2; -.
DR   BioMuta; SLK; -.
DR   DMDM; 74762732; -.
DR   EPD; Q9H2G2; -.
DR   MaxQB; Q9H2G2; -.
DR   PaxDb; Q9H2G2; -.
DR   PeptideAtlas; Q9H2G2; -.
DR   PRIDE; Q9H2G2; -.
DR   Ensembl; ENST00000335753; ENSP00000336824; ENSG00000065613. [Q9H2G2-2]
DR   Ensembl; ENST00000369755; ENSP00000358770; ENSG00000065613. [Q9H2G2-1]
DR   GeneID; 9748; -.
DR   KEGG; hsa:9748; -.
DR   UCSC; uc001kxo.2; human. [Q9H2G2-1]
DR   CTD; 9748; -.
DR   DisGeNET; 9748; -.
DR   GeneCards; SLK; -.
DR   HGNC; HGNC:11088; SLK.
DR   HPA; HPA015757; -.
DR   MIM; 616563; gene.
DR   neXtProt; NX_Q9H2G2; -.
DR   OpenTargets; ENSG00000065613; -.
DR   PharmGKB; PA35941; -.
DR   eggNOG; KOG0579; Eukaryota.
DR   eggNOG; ENOG410XPQN; LUCA.
DR   GeneTree; ENSGT00810000125351; -.
DR   HOVERGEN; HBG052712; -.
DR   InParanoid; Q9H2G2; -.
DR   KO; K08836; -.
DR   OMA; DQEKQQM; -.
DR   OrthoDB; EOG091G01Y1; -.
DR   PhylomeDB; Q9H2G2; -.
DR   TreeFam; TF351445; -.
DR   SignaLink; Q9H2G2; -.
DR   SIGNOR; Q9H2G2; -.
DR   EvolutionaryTrace; Q9H2G2; -.
DR   GeneWiki; SLK_(gene); -.
DR   GenomeRNAi; 9748; -.
DR   PMAP-CutDB; Q9H2G2; -.
DR   PRO; PR:Q9H2G2; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   Bgee; ENSG00000065613; -.
DR   CleanEx; HS_SLK; -.
DR   Genevisible; Q9H2G2; HS.
DR   GO; GO:0031252; C:cell leading edge; ISS:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0045296; F:cadherin binding; IDA:BHF-UCL.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:UniProtKB.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB.
DR   GO; GO:0004702; F:signal transducer, downstream of receptor, with serine/threonine kinase activity; IBA:GO_Central.
DR   GO; GO:0006915; P:apoptotic process; IEA:UniProtKB-KW.
DR   GO; GO:0031122; P:cytoplasmic microtubule organization; IMP:UniProtKB.
DR   GO; GO:0046777; P:protein autophosphorylation; IDA:UniProtKB.
DR   GO; GO:0042981; P:regulation of apoptotic process; IDA:UniProtKB.
DR   GO; GO:0030334; P:regulation of cell migration; IMP:UniProtKB.
DR   GO; GO:0051893; P:regulation of focal adhesion assembly; IDA:UniProtKB.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR022165; PKK.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   InterPro; IPR001943; UVR_dom.
DR   Pfam; PF00069; Pkinase; 1.
DR   Pfam; PF12474; PKK; 2.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
DR   PROSITE; PS50151; UVR; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Apoptosis; ATP-binding;
KW   Coiled coil; Complete proteome; Cytoplasm; Kinase; Nucleotide-binding;
KW   Phosphoprotein; Polymorphism; Reference proteome;
KW   Serine/threonine-protein kinase; Transferase.
FT   CHAIN         1   1235       STE20-like serine/threonine-protein
FT                                kinase.
FT                                /FTId=PRO_0000233239.
FT   DOMAIN       34    292       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   DOMAIN      875    910       UVR. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00217}.
FT   NP_BIND      40     48       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   COILED      826   1069       {ECO:0000255}.
FT   COILED     1109   1183       {ECO:0000255}.
FT   COMPBIAS     16     19       Poly-Lys.
FT   COMPBIAS    302    652       Glu-rich.
FT   ACT_SITE    155    155       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10027}.
FT   BINDING      63     63       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   SITE        438    439       Cleavage; by caspase-3. {ECO:0000250}.
FT   MOD_RES      14     14       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     183    183       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:O54988}.
FT   MOD_RES     189    189       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:19369195,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     330    330       Phosphoserine.
FT                                {ECO:0000244|PubMed:18691976}.
FT   MOD_RES     340    340       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O08815}.
FT   MOD_RES     341    341       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     344    344       Phosphoserine.
FT                                {ECO:0000244|PubMed:19369195}.
FT   MOD_RES     347    347       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:21406692}.
FT   MOD_RES     348    348       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:21406692}.
FT   MOD_RES     354    354       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O54988}.
FT   MOD_RES     372    372       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     518    518       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     565    565       Phosphoserine.
FT                                {ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:19369195,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     569    569       Phosphothreonine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     571    571       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     647    647       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O54988}.
FT   MOD_RES     655    655       Phosphoserine.
FT                                {ECO:0000244|PubMed:18691976}.
FT   MOD_RES     667    667       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O54988}.
FT   MOD_RES     777    777       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     779    779       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     814    814       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     818    818       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1097   1097       Phosphothreonine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   VAR_SEQ     929    959       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:10699464,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:9039502}.
FT                                /FTId=VSP_018100.
FT   VARIANT     405    405       Q -> K (in a lung adenocarcinoma sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041080.
FT   VARIANT     552    552       C -> Y (in dbSNP:rs805657).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041081.
FT   VARIANT     604    604       E -> Q (in an ovarian serous carcinoma
FT                                sample; somatic mutation;
FT                                dbSNP:rs190220654).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041082.
FT   VARIANT     658    658       A -> G (in dbSNP:rs56400929).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041083.
FT   VARIANT     666    666       G -> E (in dbSNP:rs7071400).
FT                                /FTId=VAR_051666.
FT   VARIANT     679    679       I -> T (in dbSNP:rs34326537).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041084.
FT   VARIANT     683    683       K -> N (in dbSNP:rs35389916).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041085.
FT   VARIANT     697    697       T -> I (in dbSNP:rs3740469).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041086.
FT   MUTAGEN      63     63       K->R: Loss of activity.
FT                                {ECO:0000269|PubMed:10699464}.
FT   CONFLICT      5      5       N -> S (in Ref. 3; BAA13195).
FT                                {ECO:0000305}.
FT   STRAND       26     28       {ECO:0000244|PDB:4USF}.
FT   HELIX        30     32       {ECO:0000244|PDB:4USF}.
FT   STRAND       34     40       {ECO:0000244|PDB:4USF}.
FT   HELIX        41     43       {ECO:0000244|PDB:4USF}.
FT   STRAND       46     53       {ECO:0000244|PDB:4USF}.
FT   TURN         54     56       {ECO:0000244|PDB:4USF}.
FT   STRAND       59     66       {ECO:0000244|PDB:4USF}.
FT   HELIX        70     85       {ECO:0000244|PDB:4USF}.
FT   STRAND       94    100       {ECO:0000244|PDB:4USF}.
FT   STRAND      103    109       {ECO:0000244|PDB:4USF}.
FT   HELIX       116    123       {ECO:0000244|PDB:4USF}.
FT   HELIX       129    148       {ECO:0000244|PDB:4USF}.
FT   HELIX       158    160       {ECO:0000244|PDB:4USF}.
FT   STRAND      161    163       {ECO:0000244|PDB:4USF}.
FT   STRAND      169    171       {ECO:0000244|PDB:4USF}.
FT   HELIX       181    187       {ECO:0000244|PDB:2J51}.
FT   HELIX       199    203       {ECO:0000244|PDB:4USF}.
FT   HELIX       207    209       {ECO:0000244|PDB:4USF}.
FT   HELIX       214    230       {ECO:0000244|PDB:4USF}.
FT   TURN        234    237       {ECO:0000244|PDB:4USF}.
FT   HELIX       240    242       {ECO:0000244|PDB:4USF}.
FT   HELIX       243    249       {ECO:0000244|PDB:4USF}.
FT   HELIX       258    260       {ECO:0000244|PDB:4USF}.
FT   HELIX       263    272       {ECO:0000244|PDB:4USF}.
FT   TURN        277    279       {ECO:0000244|PDB:4USF}.
FT   HELIX       283    286       {ECO:0000244|PDB:4USF}.
FT   HELIX       290    292       {ECO:0000244|PDB:4USF}.
FT   HELIX       298    308       {ECO:0000244|PDB:4USF}.
SQ   SEQUENCE   1235 AA;  142695 MW;  53A43E7CA29B0ED3 CRC64;
     MSFFNFRKIF KLGSEKKKKQ YEHVKRDLNP EDFWEIIGEL GDGAFGKVYK AQNKETSVLA
     AAKVIDTKSE EELEDYMVEI DILASCDHPN IVKLLDAFYY ENNLWILIEF CAGGAVDAVM
     LELERPLTES QIQVVCKQTL DALNYLHDNK IIHRDLKAGN ILFTLDGDIK LADFGVSAKN
     TRTIQRRDSF IGTPYWMAPE VVMCETSKDR PYDYKADVWS LGITLIEMAE IEPPHHELNP
     MRVLLKIAKS EPPTLAQPSR WSSNFKDFLK KCLEKNVDAR WTTSQLLQHP FVTVDSNKPI
     RELIAEAKAE VTEEVEDGKE EDEEEETENS LPIPASKRAS SDLSIASSEE DKLSQNACIL
     ESVSEKTERS NSEDKLNSKI LNEKPTTDEP EKAVEDINEH ITDAQLEAMT ELHDRTAVIK
     ENEREKRPKL ENLPDTEDQE TVDINSVSEG KENNIMITLE TNIEHNLKSE EEKDQEKQQM
     FENKLIKSEE IKDTILQTVD LVSQETGEKE ANIQAVDSEV GLTKEDTQEK LGEDDKTQKD
     VISNTSDVIG TCEAADVAQK VDEDSAEDTQ SNDGKEVVEV GQKLINKPMV GPEAGGTKEV
     PIKEIVEMNE IEEGKNKEQA INSSENIMDI NEEPGTTEGE EITESSSTEE MEVRSVVADT
     DQKALGSEVQ DASKVTTQID KEKKEIPVSI KKEPEVTVVS QPTEPQPVLI PSININSDSG
     ENKEEIGSLS KTETILPPES ENPKENDNDS GTGSTADTSS IDLNLSISSF LSKTKDSGSI
     SLQETRRQKK TLKKTRKFIV DGVEVSVTTS KIVTDSDSKT EELRFLRRQE LRELRFLQKE
     EQRAQQQLNS KLQQQREQIF RRFEQEMMSK KRQYDQEIEN LEKQQKQTIE RLEQEHTNRL
     RDEAKRIKGE QEKELSKFQN MLKNRKKEVI NEVEKAPKEL RKELMKRRKE ELAQSQHAQE
     QEFVQKQQQE LDGSLKKIIQ QQKAELANIE RECLNNKQQL MRAREAAIWE LEERHLQEKH
     QLLKQQLKDQ YFMQRHQLLK RHEKETEQMQ RYNQRLIEEL KNRQTQERAR LPKIQRSEAK
     TRMAMFKKSL RINSTATPDQ DRDKIKQFAA QEEKRQKNER MAQHQKHENQ MRDLQLQCEA
     NVRELHQLQN EKCHLLVEHE TQKLKELDEE HSQELKEWRE KLRPRKKTLE EEFARKLQEQ
     EVFFKMTGES ECLNPSTQSR ISKFYPIPSL HSTGS
//
